Publication | Closed Access

Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin

Tumor BiologyBreast OncologyProduct 4′MedicinePharmacologyCancer Cell BiologyHydroxy TangeretinCancer BiologyBreast CancerAnti-cancer AgentOncologyCell BiologyCancer ResearchMolecular OncologyCancer Metabolism